Lynn Kramer

11:32
Outstanding amyloid response to BAN2401: slowing progression in early Alzheimer’s
Lynn Kramer et al.
10:19
Clinical trial for BAN2401 in early Alzheimer’s: combining ADCOMS and Bayesian statistics
Lynn Kramer
The content of VJDementia is intended for healthcare professionals